3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
23
Recurrence
3
Neoplasms, Plasma Cell
2
Lymphoma
2
beta-Thalassemia
1
Thalassemia
1
Sarcoma, Myeloid
1
Prostatic Neoplasms
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Plasmablastic Lymphoma
1
Neoplasms
1
Multi-centric Castleman's Disease
1
Macular dystrophy, corneal type 1
1
Lymphoproliferative Disorders
1
Lymphoma, Mantle-Cell
1
Lymphadenopathy
1
Leukemia, Myeloid, Acute
1
HIV Infections
1
Anemia, Sickle Cell
1
Interventions
Magnetic Resonance Spectroscopy
4
Cyclophosphamide
4
Specimen Handling
3
Biopsy
3
sodium-iodide symporter
2
fludarabine
2
cemiplimab
2
X-Rays
2
Whole-Body Irradiation
2
Stem Cell Transplantation
2
Photons
2
Nivolumab
2
Mycophenolic Acid
2
Immunoglobulin G
2
Disulfides
2
Cyclosporine
2
treosulfan
1
ruxolitinib
1
pembrolizumab
1
fludarabine phosphate
1
entrectinib
1
duvelisib
1
alectinib
1
Vinblastine
1
Tacrolimus
1
Standard of Care
1
Sirolimus
1
Practice Guidelines as Topic
1
Peripheral Blood Stem Cell Transplantation
1
Methotrexate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, Large-Cell, Anaplastic
×
Bortezomib
×
30 days
×
Clear all
No trials found.